my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
16-02-2006: BD (Becton, Dickinson and Company) announced the completion of its acquisition of GeneOhm Sciences, Inc., a pioneer in the development of molecular diagnostic testing for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs), a growing global healthcare problem. The acquisition was finalized in accordance with terms originally disclosed in an announcement issued by BD on January 10, 2006.
BD will implement a broad, global initiative to work with hospitals, governments and other related parties to address the challenge of reducing HAIs. The GeneOhm Sciences array of rapid molecular assays for detection of these "super bugs" will offer important tools to address the diagnostic challenge of providing almost immediate detection of these harmful, infection-causing organisms. Ensuring prompt identification of bacteria, such as MRSA (methicillin resistant Staphylococcus aureus), enables the appropriate and directed drug therapy to commence sooner, and it can significantly impact patient and economic outcomes, a primary customer expectation. BD expects to bring its proven educational, training and in-service resources to this problem to assist physicians, nurses and others in a highly collaborative effort to reduce illness and mortality associated with HAIs.
Watchlist
This is where you can add this news to your personal favourites
BD (Becton, Dickinson and Company) announced the release of a study by researchers from the Johns Hopkins Bloomberg School of Public Health at the XVI International AIDS Conference (AIDS 2006) that demonstrated conducting CD4 tests is a cost-effective laboratory testing strategy for managin ... more
BD Biosciences, a segment of BD, announced a licensing and research agreement with Dynomics BV in the fields of leukemia and lymphoma. Under terms of the agreement, BD has an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion prot ... more
BD Completes Acquisition of GeneOhm Sciences, Inc.
BD (Becton, Dickinson and Company) announced the completion of its acquisition of GeneOhm Sciences, Inc., a pioneer in the development of molecular diagnostic testing for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs), a gr ... more
Personal flow cytometer BD Accuri™ C6 brings cell analysis within reach
The analytical power and versatility of today's laser-based flow cytometry systems have unlocked the mysteries of cell biology and empowered entirely more
BD Cytometric Bead Array: Multiplexed quantitation and detection
BD™ Cytometric Bead Array (CBA) is a flow cytometry application that allows users to quantify multiple proteins simultaneously. The BD CBA system uses more
Heavy and light chain isotypes of mouse IgG1, IgG2a, IgG2b, IgG3, IgA, IgM, and IgE (Anti-Mouse)
BD™ CBA Mouse Immunoglobulin Isotyping Kit more
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. We are focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discove ... more
Right from the start, BD SENSORS has specialized in electronic pressure and level measurement. Apart from an extensive product program BD SENSORS almost offers for each application a suitable solution more
Becton Dickinson de Colombia Ltda.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious di ... more
BD Completes Acquisition of GeneOhm Sciences, Inc.
BD (Becton, Dickinson and Company) announced the completion of its acquisition of GeneOhm Sciences, Inc., a pioneer in the development of molecular diagnostic testing for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs), a gr ... more
BD Announces Agreement to Acquire GeneOhm Sciences, Inc.
BD (Becton, Dickinson and Company) announced that it has signed an agreement to acquire GeneOhm Sciences, Inc. GeneOhm Sciences had 2005 revenues of approximately $5 million and provides BD with expanded entry into the emerging HAI (healthcare-associated infections) market. Today, nearly 6 ... more
GeneOhm Sciences announces year long MRSA study in the United Kingdom
GeneOhm Sciences announced the beginning of a year-long pilot study, commissioned by the UK Department of Health, of proactive patient screening to detect colonization by methicillin-resistant Staphylococcus aureus (MRSA). The program, which will be implemented at Birmingham Heartlands and ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
